BackTvardi Therapeutics Overview

Tvardi Therapeutics Profit Margin

Valuation check: TVRD's profit margin is 1219.66%, above the Healthcare sector average of 21.75%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Sep 2026

Annual Profit Margin (TTM)

1219.66%
↑ 451.95% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Tvardi Therapeutics (TVRD) FAQ

As of the most recent data (September 2026), TVRD shows a profit margin of 1219.66%. That compares with -346.55% in the prior-year period — up 451.9% year over year. That is above the Healthcare sector average of 21.75%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TVRD's profit margin is now 1219.66% (was -346.55%) — a 451.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Tvardi Therapeutics is outperforming or lagging.

The Healthcare sector average profit margin is about 21.75%. Tvardi Therapeutics is at 1219.66%, which is higher that average. That is roughly 5508.4% above the sector mean. Use the comparison chart on this page to see how TVRD stacks up against individual peers as well.

That compares with -346.55% in the prior-year period — up 451.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Tvardi Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Tvardi Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 1219.66%) with ownership activity and broader fundamentals.

Questions & Answers